Vasopressin Clinical Trials

4 actively recruiting trials across 2 locations

No change since May 2026

Also known as: Antidiuretic Hormone, Pitressin

Pipeline

Phase 2: 1Phase 4: 1

Top Sponsors

University of Chicago1
Samuel Lunenfeld Research Institute, Mount Sinai Hospital1
Jason Sperry1
Hospital Universitario 12 de Octubre1

Indications

Diabetes4
Shock2
Vasopressin Deficiency1
Vasopressor Adverse Reaction1
Vasopressin Causing Adverse Effects in Therapeutic Use1

Other2 trials

Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro Study

N/A

Registry of Patients in Shock Treated With Vasopressin

Tucson, Arizona1 trial

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

University of Arizona

Phase 2

Chicago, Illinois1 trial

Vasoactive Drugs in Intensive Care Unit

University of Chicago Medical Center

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.